
Chemicals · BSE
Alkosign Limited is engaged in the manufacturing of visual presentation systems such as writing boards, display boards and notice boards along with related accessories, and also produces board stands, school benches, desks and allied products, which are marketed under brands including Alkosign, Sit and Study, Brainee, Glassy-BO, Ultra-EX and Ultra. The company supplies its products across around 22 Indian states through a network of nearly 50 registered dealers, sells through its own website and e-commerce platforms, and is expanding into international markets, supported by India’s largest dedicated manufacturing facility for writing and display boards with over 5,00,000 sq. ft. of production space.
Price Band
₹45
Issue Size
₹12.15 Cr
Lot Size
3000 shares
GMP
Est. Listing
₹45
at current GMP
Subscribed
—
Open
18 Jan 2022
Close
21 Jan 2022
Allotment
27 Jan 2022
Refund
28 Jan 2022
Demat Credit
29 Jan 2022
Listing
1 Feb 2022
Overall Subscription
0.00x
Total Demand
QIB Multiplier
0.00x
Institutions & Funds
NII / HNI
0.00x
High Net-Worth
Retail (RII)
0.00x
Individual Bidders
Live bidding breakdown by institutional, non-institutional, and retail investors
| Category | Shares Offered | Shares Applied / Bid | Times Subscribed |
|---|---|---|---|
| Qualified Institutional (QIB) | 1,350,000 | — | 0.00x |
| Non-Institutional (NII / HNI) | 405,000 | — | 0.00x |
| Retail Individual (RII) | 945,000 | — | 0.00x |
| Total | 2,700,000 | 0 | 0.00x |
Total unique applications received across retail and HNI tranches
| Category | Applications Reserved | Applications Received | Times Subscribed |
|---|---|---|---|
| Retail (RII) | 315 | 315 | 1.00x |
| HNIs (10L +) | 2 | 2 | 1.00x |
| HNIs (2-10L) | 10 | 10 | 1.00x |
| Total Applications | 327 | 327 | 1.00x |
Track continuous institutional and retail bidding order books for all active issues on the ipo live subscription feed.
Alkosign Limited is bringing an initial public offering (IPO) in the Chemicals sector with an aggregate issue size of ₹12.15 Crores. The shares are offered at a price band of ₹45 to ₹45 per equity share on BSE. Currently, market analysts recommend evaluating the company's financial valuation, price-to-earnings (P/E) multiple, and peer comparison prior to submitting bids.
The public offer consists of a fresh issue and offer-for-sale structured under SEBI regulations. Bidding is open to Qualified Institutional Buyers (QIB), Non-Institutional Bidders (NII/HNI), and Retail Individual Investors (RII). Applications can be submitted online using ASBA or UPI mandate through certified stock brokers and net banking portals.
Following the close of bidding on 2022-01-21, the basis of allotment is scheduled to be finalized on 2022-01-27. Investors can verify their application status online by submitting their PAN card number, Application Number, or DP Client ID on the registrar's official portal (Skyline Financial Services Private Limited) or the BSE allotment checking window.
Currently, Alkosign Limited IPO Grey Market Premium (GMP) is not actively quoted or is quoted flat at ₹0. The shares are expected to list close to the issue price band of ₹45 to ₹45 per equity share.
The retail lot size is 3000 shares requiring a minimum application amount of ₹1,35,000. Expected listing price is ₹45 per equity share.
The Alkosign Limited IPO aggregate issue size is ₹12.15 Crores with an equity price band set at ₹45 to ₹45 per equity share. The retail lot size is 3000 shares requiring a minimum capital outlay of approx. ₹1,35,000.
Live subscription figures are compiled real-time from the NSE and BSE bidding engines. Currently, overall subscription is 0.00x (Retail: 0.00x, QIB: 0.00x, NII: 0.00x). You can track live multiples directly on our dedicated subscription page.
The basis of allotment will be published on the official registrar portal (Skyline Financial Services Private Limited) and the BSE status verification website on or around 2022-01-27. Investors can verify status using PAN card or application number.
Alkosign Limited shares are scheduled to list on BSE on 2022-02-01.